Superworth

Phibro Animal Health price to book ratio PAHC

Market value divided by the book value of the company's net assets, since 2014.

Today, Oct 23, 2026
4.1×
10-year median
4.2×
Against its 10-year history
48th
percentile: 0 is its lowest day, 100 its highest
10-year range
1.4× to 11.5×
Peer median
2.4×

Phibro Animal Health's price to book ratio is 4.1× as of Oct 23, 2026.

That is below its ten-year median of 4.2×, close to the middle of its last ten years.

Over that time it ranged from 1.4× in Nov 2023 to 11.5× in Dec 2016.

The median for 10 large drugmakers of a similar size is 2.4×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far4.1×3.5×7.1×
20255.0×2.8×6.0×
20243.3×1.6×3.8×
20231.7×1.4×2.5×
20222.1×1.9×3.7×
20213.5×3.3×5.6×
20204.1×3.3×5.7×
20194.9×3.9×7.1×
20186.7×6.6×11.0×
20177.9×7.8×11.3×
201611.3×9.3×59.2×
201552.2×41.2×66.4×
201455.3×53.6×72.9×

Against its peers

Companies in Drug Manufacturers - General nearest Phibro Animal Health's size, closest first, today.

CompanyPrice to book ratio
PAHCPhibro Animal Health4.1×
ANIPANI Pharmaceuticals2.8×
ANABAnaptysbio138×
PCRXPacira BioSciences2.2×
OMEROmerosn/m
HRMYHarmony Biosciences2.1×
PBHPrestige Consumer Healthcare1.2×
AMPHAmphastar Pharmaceuticals1.4×
NRIXNurix Therapeutics2.9×
ABUSArbutus Biopharma3.2×
COLLCollegium Pharmaceutical2.4×
Peer median2.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Phibro Animal Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.